Document:

Amendment No. 1, dated May 18, 2005

 Exhibit 10.4 
  
 AMENDMENT NO. 1 
 TO 
 AMENDED AND RESTATED RIGHTS AGREEMENT 
  
 THIS AMENDMENT NO. 1 (this “Amendment”) to the Amended and Restated Rights Agreement (the “Rights
Agreement”) dated as of July 29, 1999 between NOVOSTE CORPORATION, a Florida corporation (the “Company”), and AMERICAN STOCK TRANSFER & TRUST COMPANY, a banking corporation organized under the laws of New York, as
rights agent (the “Rights Agent”), is entered into this 18th day of May, 2005. 
  
 WHEREAS, the Company and the Rights Agent are currently parties to the Rights Agreement and desire to amend the Rights Agreement on the terms and
conditions hereinafter set forth; 
  
 WHEREAS, the Company, ONI
Medical Systems, Inc., a Delaware corporation (“ONI”), and ONIA Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of the Company (the “Merger Subsidiary”), have entered into an Agreement and
Plan of Merger (the “Merger Agreement”) pursuant to which, among other things, the Merger Subsidiary will merge with and into ONI with ONI becoming a wholly owned subsidiary of the Company;  
  
 WHEREAS, on May 17, 2005 the Board of Directors of the Company resolved to
amend the Rights Agreement to render it inapplicable to the Merger Agreement, the Merger and other transactions specifically contemplated thereby; and 
  
 WHEREAS, for purposes of this Amendment, capitalized terms not otherwise defined herein shall have the respective meanings set forth in the Rights
Agreement, as amended by this Amendment; 
  
 NOW, THEREFORE, in
consideration of the premises and the mutual agreements herein set forth, the parties hereby agree as follows: 
  
 1. Amendment to Section 1. 
  
 (a) Section 1(a) of the Rights Agreement is hereby amended by adding the following new paragraph to the end of Section 1(a): 
  
 “Notwithstanding anything in this Agreement that might
otherwise be deemed to the contrary, and provided that the Merger Agreement has not been terminated pursuant to its terms, neither ONI, the Merger Subsidiary, nor any of either such parties’ Affiliates or Associates shall be deemed to be an
Acquiring Person solely by reason of: (i) the approval, execution or delivery of the Merger Agreement, including any amendment or supplement thereto; (ii) the announcement or consummation of the Merger; or (iii) the consummation of any of the
transactions specifically contemplated by the Merger Agreement, each upon the terms and subject to the conditions of the Merger Agreement. 
  

 -1- 

 In addition, notwithstanding anything in this Agreement that might otherwise be deemed to
the contrary, and provided that (i) the Merger Agreement has not been terminated pursuant to its terms, and (ii) as a result of the approval, execution or consummation of the Merger and/or the transactions contemplated thereby, Galen Partners IV,
LP, Galen Partners International IV, LP, Galen Employee Fund IV, LP and Claudius IV, LLC, together with their Affiliates and Associates, becomes the Beneficial Owner of 15% or more of the outstanding Common Shares at the Effective Time, Galen
Partners IV, LP, Galen Partners International IV, LP, Galen Employee Fund IV, LP and Claudius IV, LLC, together with their Affiliates and Associates, shall be deemed to be a “Qualified Exempt Person” and shall not be deemed an
“Acquiring Person”; provided however, that if after the Effective Time, the Qualified Exempt Person becomes at any time the Beneficial Owner of an additional 2% of the Common Shares then outstanding in excess of the amount of the Common
Shares such Qualified Exempt Person beneficially owned as of the Effective Time, then such Qualified Exempt Person shall be deemed an “Acquiring Person” hereunder as to all of their Common Shares beneficially owned. Notwithstanding the
foregoing, a Qualified Exempt Person shall not become an “Acquiring Person” as a result of an acquisition of Common Shares by the Company which, by reducing the number of Common Shares outstanding, increases the proportionate number of
Common Shares beneficially owned by a Qualified Exempt Person as of the Effective Time by an additional 2%, provided however, that if by reason of share purchases by the Company the proportionate number of Common Shares beneficially owned by a
Qualified Exempt Person as of the Effective Time increases by an additional 2% of the outstanding Common Shares, and thereafter the Qualified Exempt Person shall become the Beneficial Owner of an additional 1% of the outstanding Common Shares, then
the Qualified Exempt Person shall be deemed to be an “Acquiring Person” if such Qualified Exempt Person is then the Beneficial Owner of 15% or more of the outstanding Common Shares.” 
  
 (b) Section 1(i) of the Rights Agreement is hereby amended by adding the
following new paragraph to the end of Section 1(i): 
  
 “Notwithstanding anything in this Agreement that might otherwise be deemed to the contrary, and provided that the Merger Agreement has not been terminated pursuant to its terms, no Distribution Date shall be deemed to have occurred
solely by reason of: (i) the approval, execution or delivery of the Merger Agreement, including any amendment or supplement thereto; (ii) the announcement or consummation of the Merger; or (iii) the consummation of the transactions specifically
contemplated by the Merger Agreement, each upon the terms and subject to the conditions of the Merger Agreement.” 
  
 (c) Section 1 of the Rights Agreement is hereby amended by inserting the following text after section 1(i) but before Section 1(j): 
  
 “(i-1) “Effective Time” shall mean the date
that the Merger becomes effective pursuant to the terms and conditions of the Merger Agreement.” 
  

 -2- 

 (d) Section 1(l) of the Rights Agreement is hereby amended by adding the following sentence to the end of
Section 1(l): 
  
 “Notwithstanding anything in this
Agreement that might otherwise be deemed to the contrary, and provided that the Merger Agreement has not been terminated pursuant to its terms, the term “Interested Shareholder” shall not include ONI or any of its Affiliates and
Associates.” 
  
 (e) Section 1 of the Rights Agreement is
hereby amended by inserting the following text after section 1(l) but before Section 1(m): 
  
 “(l-1) “Merger” shall mean the merger of the Merger Subsidiary with and into ONI pursuant to the terms and conditions of
the Merger Agreement with ONI becoming a wholly owned subsidiary of the Company.” 
  
 (l-2) “Merger Agreement” shall mean the Agreement and Plan of Merger by and among the Company, the Merger Subsidiary and ONI,
dated as of May 18, 2005, which sets forth the terms and conditions of the Merger. 
  
 (l-3) “Merger Subsidiary” shall mean ONIA Acquisition Corp., a wholly owned subsidiary of the Company. 
  
 (l-4) “ONI” shall mean ONI Medical Systems, Inc.,
a Delaware corporation.” 
  
 (f) Section 1(v) of the Rights
Agreement is hereby amended by adding the following new paragraph to the end of Section 1(v): 
  
 “Notwithstanding anything in this Agreement that might otherwise be deemed to the contrary, and provided that the Merger Agreement
has not been terminated pursuant to its terms, no Shares Acquisition Date shall be deemed to have occurred solely by reason of: (i) the approval, execution or delivery of the Merger Agreement, including any amendment or supplement thereto; (ii) the
announcement or consummation of the Merger; or (iii) the consummation of the transactions specifically contemplated thereby, each upon the terms and subject to the conditions of the Merger Agreement.” 
  
 (g) Section 1(x) of the Rights Agreement is hereby amended by adding the
following new paragraph to the end of Section 1(x): 
  
 “Notwithstanding anything in this Agreement that might otherwise be deemed to the contrary, and provided that the Merger Agreement has not been terminated pursuant to its terms, no Transaction shall be deemed to have occurred solely by
reason of: (i) the approval, execution or delivery of the Merger 

  

 -3- 

 
Agreement, including any amendment or supplement thereto; (ii) the announcement or consummation of the Merger; or (iii) the consummation of the transactions
specifically contemplated thereby, each upon the terms and subject to the conditions of the Merger Agreement.” 
  
 2. Amendment to Section 11(a)(ii). Section 11(a)(ii) of the Rights Agreement is amended by adding the following sentence at the end thereof:

  
 “Notwithstanding anything in this
Agreement that might otherwise be deemed to the contrary, and provided that the Merger Agreement has not been terminated pursuant to its terms, none of the (i) approval, execution, delivery or performance of the Merger Agreement, (ii) the
consummation of the Merger in accordance with the provisions of the Merger Agreement, (iii) the acquisition of Common Shares in accordance with the Merger Agreement pursuant to the Merger or (iv) the consummation of any other transaction to be
effected pursuant to the Merger Agreement in accordance with the provisions of the Merger Agreement shall cause the Rights to be adjusted or become exercisable in accordance with this Section 11(a)(ii).” 
  
 3. Amendment to Section 13(e). Section 13(e) of the Rights Agreement
is amended by adding the following sentence at the end thereof: 
  
 “Notwithstanding anything in this Agreement that might otherwise be deemed to the contrary, and provided that the Merger Agreement has not been terminated pursuant to its terms, the provisions of this Section 13
shall not be applicable to the Merger.” 
  
 4. Effective
Date. This Amendment shall become effective as of the date first above written. 
  
 5. Other Terms Unchanged. The Rights Agreement, as amended by this Amendment, shall remain and continue in full force and effect and is in all respects agreed to, ratified and confirmed hereby. Any reference to
the Rights Agreement after the date first set forth above shall be deemed to be a reference to the Rights Agreement, as amended by this Amendment. 
  
 6. Benefits. Nothing in the Rights Agreement, as amended by this Amendment, shall be construed to give to any Person other than the Company, the
Rights Agent and the registered holders of the Rights Certificates (and, prior to the Distribution Date, the registered holders of the Common Stock) any legal or equitable right, remedy or claim under the Rights Agreement, as amended by this
Amendment; but the Rights Agreement, as amended by this Amendment, shall be for the sole and exclusive benefit of the Company, the Rights Agent and the registered holders of the Rights Certificates (and, prior to the Distribution Date, registered
holders of the Common Stock). 
  

 -4- 

 7. Descriptive Headings. Descriptive headings of the several Sections of this Amendment are
inserted for convenience only and shall not control or affect the meaning or construction of any of the provisions hereof. 
  
 8. Governing Law. This Amendment shall be deemed to be a contract made under the laws of the State of Florida and for all purposes shall be
governed by and construed in accordance with the laws of such State. 
  
 9. Counterparts. This Amendment may be executed in any number of counterparts. It shall not be necessary that the signature of or on behalf of each party appears on each counterpart, but it shall be sufficient that the signature of
or on behalf of each party appears on one or more of the counterparts. All counterparts shall collectively constitute a single agreement. It shall not be necessary in any proof of this Amendment to produce or account for more than a number of
counterparts containing the respective signatures of or on behalf of all of the parties. 
  
 10. Fax Transmission. A facsimile, telecopy or other reproduction of this Amendment may be executed by one or more parties hereto, and an executed copy of this Amendment may be delivered by one or more parties
hereto by facsimile or similar instantaneous electronic transmission device pursuant to which the signature of or on behalf of such party can be seen, and such execution and delivery shall be considered valid, binding and effective for all purposes.
At the request of any party hereto, all parties agree to execute an original of the Amendment as well as any facsimile, telecopy or other reproduction thereof. 
  

[Signatures on Next Page] 
  

 -5- 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and attested, all
as of the day and year first above written. 
  

			
	 NOVOSTE CORPORATION

		
	 By:
	 	 /s/ Alfred J. Novak

	 Name:
	 	 Alfred J. Novak

	 Title:
	 	 President and Chief Executive Officer

	
	AMERICAN STOCK TRANSFER & TRUST COMPANY, as Rights Agent
		
	 By:
	 	 /s/ Isaac J. Kagan

	 Name:
	 	 Isaac J. Kagan

	 Title:
	 	 Vice President

  

 -6-Form of 2006 Stock Appreciation Rights Plan for Key Employees

 EXHIBIT 10.1 
  
  
  
 AZZ incorporated 
 FISCAL YEAR 2006 STOCK APPRECIATION RIGHTS 
 PLAN FOR KEY EMPLOYEES 
  
 DATED May 18, 2005 
  
  

 AZZ incorporated 
 FISCAL YEAR 2006 STOCK APPRECIATION RIGHTS 
 PLAN FOR KEY EMPLOYEES 
  
 TABLE OF CONTENTS 
  

	
	
	ARTICLE 1 Purpose of Plan
	
	ARTICLE 2 Administration of Plan
	
	ARTICLE 3 Eligibility and Grant
	
	ARTICLE 4 Terms of Rights
	
	ARTICLE 5 Limitations on Number of Rights and Date of Grant
	
	ARTICLE 6 Appreciation Amount
	
	ARTICLE 7 Payment of Appreciation Amount
	
	ARTICLE 8 Nature of Rights
	
	ARTICLE 9 Termination of Rights
	
	ARTICLE 10 Adjustment to Rights
	
	ARTICLE 11 Termination and Amendment
	
	ARTICLE 12 Rights Agreement
	
	ARTICLE 13 Miscellaneous Provisions
	
	ARTICLE 14 Definitions

 AZZ incorporated, a Texas corporation (the “Company”), hereby establishes and sets forth the
terms of the AZZ incorporated, FISCAL YEAR 2006 STOCK APPRECIATION RIGHTS PLAN FOR KEY EMPLOYEES (the “Plan”) to be effective May 18, 2005. 
  
 ARTICLE 1. PURPOSE OF PLAN 
  
 The purpose of this Plan is to enable the Company to attract and retain key employees of the highest caliber by offering to them an opportunity to share
in increases in the value of the Company to which they contribute. This Plan will seek to accomplish this purpose by granting such employees stock appreciation rights (collectively, the “Rights” and individually, a “Right”),
which will be associated with shares of common stock of the Company, one dollar ($1.00) par value (the “Common Stock”), and which will be subject to all of the terms and conditions contained in this Plan. 
  
 ARTICLE 2. ADMINISTRATION OF PLAN 
  
 2.1 This Plan shall be administered by the Compensation Committee of
the Board of Directors of the Company (the “Administrative Committee”). 
  
 2.2 A majority of the members of the Administrative Committee shall constitute a quorum. All actions of the Administrative Committee shall require the affirmative vote of members who constitute a majority of
such quorum. 
  
 2.3 The Administrative Committee shall
have the following rights and powers: 
  

	 	(a)	The Administrative Committee shall have the authority (i) to administer this Plan in accordance with its express terms; (ii) to determine all questions arising in connection with
the administration, interpretation, and application of this Plan, including all questions relating to the fair market value of the Common Stock; (iii) to correct any defect, supply any information and reconcile any inconsistency in the Plan in such
manner and to such extent as shall be deemed necessary or advisable to carry out the purpose of this Plan; (iv) to prescribe, amend and rescind rules and regulations relating to the administration of this Plan; and (v) to make all other
determinations and to take all actions necessary or advisable for administration of this Plan provided, however, no action taken under the authority of this Section 2.3(a) shall be contrary to any specific provisions in the Plan.

  

	 	(b)	All determinations made by the Administrative Committee on matters referred to in this Section 2.3 shall be final, conclusive and binding upon all persons and shall, except as
expressly provided to the contrary in this Plan, be at the sole discretion of the Administrative Committee. The Administrative Committee shall have all powers necessary or appropriate to accomplish its duties under this Plan or to administer this
Plan. 

 ARTICLE 3. ELIGIBILITY AND GRANT 
  
 3.1 An individual shall be eligible to participate in this Plan provided that such individual (i) is an employee of
the Company or a Subsidiary of the Company (as defined below), (ii) is determined by the Administrative Committee to be a key employee of the Company or a Subsidiary of the Company, and (iii) is selected by the Administrative Committee to receive
Rights under this Plan. 
  
 3.2 A key employee of the
Company so selected by the Administrative Committee may be granted a Right only by a written Stock Appreciation Rights Agreement signed by the Company and such key employee, in form and substance approved by the Administrative Committee, in
accordance with Article 12 hereof. Each key employee of the Company who so enters into a written Stock Appreciation Rights Agreement with the Company shall sometimes be referred to in this Plan as a “Holder.” 
  
 ARTICLE 4. TERMS OF RIGHTS 
  
 Each Right granted to a Holder selected by the Administrative Committee in
accordance with Section 3 shall have the following terms: 
  
 4.1 The Right shall be granted effective as of the effective date of the Stock Appreciation Rights Agreement evidencing the grant of the Right; 
  

4.2 The Right shall be associated with one share of Common Stock; 
  
 4.3 Unless it earlier terminates as provided in Section 9, the Right shall vest (if the Holder is still employed by
the Company at such time) upon the public release of financial results by the Company for its fiscal year ending on February 29, 2008 (the “Normal Vesting Date”) or (if the Holder is still employed by the Company at such time) upon the
occurrence of an Accelerating Event under Section 10.2, which shall accelerate vesting (the “Accelerated Vesting Date”) as provided in Section 10.2; 
  

4.4 Each Right shall have a base value (the “Base Value”) equal to the average of the closing prices of one share of the Common Stock
as listed on the New York Stock Exchange for those days on which it trades during the ninety calendar days period immediately following the public release of financial results for the Company’s fiscal year ended February 28, 2005; and

  
 4.5 Each Right shall be subject to such other terms and
conditions as the Administrative Committee deems advisable and as are consistent with the terms and conditions of this Plan. Except as expressly provided herein, nothing contained in this Plan shall require that the terms and conditions of Rights
granted hereunder be uniform. 
  
  

 ARTICLE 5. LIMITATIONS ON NUMBER OF RIGHTS AND DATE OF GRANT 
  
 5.1 The aggregate number of Rights that may be granted under this
Plan and the maximum number of Rights which may be granted to any one individual during any calendar year shall be [one hundred fifteen thousand (115,000)]. This number shall be subject to any adjustment required or permitted pursuant to the
provisions of Section 10. 
  
 5.2 No Rights may be granted
under this Plan after May 18, 2005. 
  
 ARTICLE 6. APPRECIATION
AMOUNT 
  
 6.1 Effective as of the Normal Vesting Date
or Accelerated Vesting Date of a Right, the Holder of the Right shall have the full, unconditional and nonforfeitable ownership of the Right and shall be entitled to receive the amount by which the fair market value (the “FMV”) of one
share of Common Stock as determined by the methods provided below exceeds the Base Value of the Right (the “Appreciation Amount”). Prior to the occurrence of a Normal Vesting Date or Accelerated Vesting Date, a Right may be terminated or
otherwise adjusted as allowed herein. 
  
 6.2 The FMV for
the purpose of calculating the Appreciation Amount for a Right that reaches maturity on the Normal Vesting Date, shall be the average of the closing prices of one share of the Common Stock on the New York Stock Exchange for those days on which it
traded during the ninety calendar days period immediately following the public release of financial results for the Company’s fiscal year ended February 29, 2008 (the “Normal Determination Period”). The FMV for the purpose of
calculating the Appreciation Amount for a Right that reaches maturity on an Accelerated Vesting Date shall be determined as set forth in Section 10.2 below (an “Accelerated Determination Period”). 
  
 ARTICLE 7. PAYMENT OF APPRECIATION AMOUNT 
  

	 	7.1   (a)	Within thirty (30) days following the expiration of the Normal Determination Period or, if applicable, an Accelerated Determination Period of a Right, the Company shall pay the
Appreciation Amount for each SAR which has vested (the Appreciation Amount times the number of Rights), without interest, to the Holder. 

  

	 	(a)	 In no event shall payment occur after the expiration of two and one-half months after the end of the Holder’s taxable year in which the Normal Vesting Date or,
if applicable, the Accelerated Vesting Date occurs. The Normal Determination Period or, if applicable, the Accelerated Determination Period shall be shortened to the extent necessary to comply with the immediately preceding sentence. In such case,
the Administrative Committee shall determine the length of any shortened determination period, and its determination shall be binding on all parties. This Section 7.1(b) is intended to comply with the short-term deferral exception to the
requirements of 

	 	 
section 409A of the Code and shall be construed and administered in a manner that qualifies for a good faith interpretation of such exception.

  
 7.2 In the event of the death of a
Holder of a Right, that has not been terminated, the right to receive any Appreciation Amounts due to the Holder pursuant to this Plan may pass to the person or persons entitled thereto pursuant to the will of the Holder or, if no such will exists,
pursuant to applicable laws of descent and distribution. 
  
 7.3 The Company shall be entitled to deduct from any payment required by this Plan (including any Appreciation Amounts payable under Section 10.2) any amounts that the Company is required by applicable federal, state or local law to
withhold therefrom on account of employment, income or similar taxes. 
  
 ARTICLE 8. NATURE OF RIGHTS 
  
 8.1 The
Rights are intended solely as a means to measure the Appreciation Amounts that may become payable under this Plan. The Rights shall not constitute equity or other securities of the Company, and Holders of Rights shall not be shareholders of the
Company and shall not have any right of access to financial or other information regarding the Company. The Company shall not be required to set aside any amounts for purposes of this Plan, in trust or otherwise, in advance of the respective dates
prescribed for the payment of Appreciation Amounts. All Holders shall, except as otherwise provided by law, be general creditors of the Company with respect to the Rights and the right to payment of any Appreciation Amounts under this Plan.

  
 8.2 Except as expressly allowed in Section 7.2 above or
pursuant to a qualified domestic relations order (within the meaning of Section 414(p) of the Code), no Holder shall have any right to sell, assign, pledge or otherwise transfer the Rights or any other rights that the Holder may have under this
Plan, and any attempt to do so shall be void. 
  
 ARTICLE 9.
TERMINATION OF RIGHTS 
  
 All of the Rights of a Holder shall
terminate if the Holder sells, assigns, pledges or otherwise transfers, or attempts to sell, assign, pledge or otherwise transfer, any Rights or any other rights that the Holder may have under this Plan; provided, however, that the foregoing shall
not apply to a transfer occurring upon the death of the Holder pursuant to the will of the Holder or applicable laws of descent and distribution or to a transfer or assignment pursuant to a qualified domestic relations order (within the meaning of
Section 414(p) of the Code). Additionally, all the rights of a Holder shall terminate if the Holder ceases to be an employee (of either the Company or one of its Subsidiaries) prior to the Normal Vesting Date or, if applicable, the Accelerated
Vesting Date unless such termination of employment is due to death, Permanent Disability or Termination Without Cause. 

 ARTICLE 10. ADJUSTMENTS TO RIGHTS 
  
 10.1 In the event that there is a material alteration in the capital structure of the Company on account of a
reorganization, merger, recapitalization, stock split, reverse stock split, stock dividend or otherwise in which the Company is the Surviving Entity, then the Administrative Committee shall make such adjustments, if any, to the then outstanding
Rights, including the Base Price, as the Administrative Committee determines to be appropriate and equitable under the circumstances. For purposes of this Section 10.1, neither (a) the issuance of additional shares of Common Stock or other
securities of the Company in exchange for consideration (including services) of any kind nor (b) the conversion into Common Stock of any securities of the Company now or hereafter outstanding, shall be deemed material alterations in the capital
structure of the Company. Notwithstanding the foregoing, however, in the event the Administrative Committee shall determine that the nature of a material alteration in the capital structure of the Company is such that it is not feasible or advisable
to make adjustments to the Rights, the Administrative Committee may declare a Restructuring Event to have occurred, in which case an Accelerated Vesting Date will be established as provided in Section 10.2(i). 
  
 10.2 In the event of (i) a Restructuring Event, (ii) the dissolution
or liquidation of the Company, a merger or other reorganization of the Company with one or more entities as a result of which the Company will not be the Surviving Entity, or a sale of all or substantially all of the assets of the Company, (iii) a
Change in Control, (iv) a voluntary or involuntary petition is filed for or against the estate of the Holder under the bankruptcy laws of the United States or under the insolvency laws of any state, and in the case of an involuntary petition, the
petition is not dismissed within sixty (60) days following the date of filing thereof, or (v) the termination of the employment of a Holder due to death, Permanent Disability (as defined below) or Termination Without Cause, (each an
“Accelerating Event”), an Accelerated Vesting Date shall be established and a period (an “Accelerated Determination Period”) for the determination of the FMV shall be established as follows: 
  

					
	Accelerating Event	 	Accelerated Vesting Date	 	 Accelerated Determination
 Period and FMV

	(i) A Restructuring Event.	 	Date of such formal action as may be required to cause the material alteration in the Company’s capital structure.	 	Closing Price of one share of Common Stock on the New York Stock Exchange on the last day before the Vesting Date on which shares of Common Stock
traded shall be the FMV.
	(ii) Dissolution, liquidation, merger or other reorganization in which the Company is not the Surviving Entity.	 	Date of Filing of Articles of Dissolution or Articles of Merger or other documents formalizing a reorganization.	 	Closing Price of one share of Common Stock on the New York Stock Exchange on the last day before the Vesting Date on which shares of Common Stock
traded shall be the FMV.

					
	(iii) Change in Control.	 	Public announcement of an event constituting a Change in Control.	 	The average of the closing prices of one share of the Common Stock on the New York Stock Exchange for those days on which it trades during the fifteen
(15) calendar days immediately following the Accelerated Vesting Date shall be the FMV.
	(iv) Bankruptcy	 	The date a voluntary petition is filed or sixty days following the date of filing of an involuntary petition, if not dismissed by that date.	 	The average of the closing prices of one share of the Common Stock on the New York Stock Exchange for those days on which it trades during the fifteen
(15) calendar days immediately following the Accelerated Vesting Date shall be the FMV.
	(v) Termination of employment due to death, Permanent Disability or Termination Without Cause.	 	The last day of the Holders’s employment by the Company.	 	The average of the closing prices of one share of the Common Stock on the New York Stock Exchange for those days on which it trades during the fifteen
(15) calendar days immediately following the Accelerated Vesting Date shall be the FMV.

  
 ARTICLE 11.
TERMINATION AND AMENDMENT 
  
 The Board of Directors may at
any time terminate, suspend or amend the terms of this Plan; provided, however, that the termination, suspension or amendment of this Plan shall not, without the consent of the Holder, alter or impair any rights or obligations with respect to any
Rights theretofore granted hereunder. 
  
 ARTICLE 12. RIGHTS
AGREEMENT 
  
 Rights granted hereunder shall be evidenced by
a Stock Appreciation Rights Agreement designating the name of the Holder, the number of Rights granted to the Holder, the method of determining the Base Value and the Normal Vesting Date and an Accelerated Vesting Date of the Rights, and such other
terms, conditions and provisions not inconsistent with the terms and conditions of this Plan as the Administrative Committee deems advisable. 
  
 ARTICLE 13. MISCELLANEOUS PROVISIONS 
  
 13.1 Nothing contained in this Plan shall obligate the Company to employ a Holder for any period nor shall this Plan interfere in any way with the
right of the Company to reduce such Holder’s compensation or benefits. 

 13.2 Subject to Section 8, the provisions of this Plan shall inure to the benefit of and be
binding upon each Holder and the heirs, successors and assigns of each Holder. 
  
 13.3 Where the context so requires, references herein to the singular shall include the plural, and vice versa, and references to a particular gender shall include either or both additional genders. 

 
 13.4 This Plan shall be construed, administered and enforced in
accordance with the laws of the United States, to the extent applicable hereto, as well as the laws of the State of Texas. 
  
 13.5 No action taken under the Plan by the Administrative Committee shall be legally binding on a Holder if it is not taken in good faith.

  
 ARTICLE 14. DEFINITIONS 
  
 14.1 As used herein, the following terms have the meaning hereinafter
set forth unless the context clearly indicates to the contrary: 
  

	 	(a)	“Change in Control” means one or more of the following events: 

  

	 	(i)	Any person within the meaning of Section 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) other than the Company (including its
affiliates, directors or executive officers) has become the beneficial owner, within the meaning of Rule 13d-3 under the Exchange Act, of 50 percent or more of the combined voting power of the Company’s then outstanding Common Stock and any
other class or classes of the Company’s outstanding securities ordinarily entitled to vote in elections of directors (collectively, “Voting Securities”) (other than through the purchase of Voting Securities from the Company); or

  

	 	(ii)	Shares representing 50 percent or more of the combined voting power of the Company’s Voting Securities are purchased pursuant to a tender offer or exchange offer (other than an
offer by the Company or its subsidiaries or affiliates); or 

  

	 	(iii)	During any two consecutive years, individuals who, at the beginning of such period constituted the entire Board of Directors, cease to constitute a majority of the Directors, unless
the election of each was approved by at least two-thirds of the Directors still in office who were Directors at the beginning of the period. 

  

	 	(b)	“Code” means the Internal Revenue Code of 1986, as amended. 

	 	(c)	“Permanent Disability” has the meaning provided for that term in Section 22(e)(3) of the Code. 

  

	 	(d)	“Subsidiary” of the Company means an entity directly or indirectly controlled by the Company. 

  

	 	(e)	“Surviving Entity” means an entity continuing after a merger, consolidation or other reorganization to which the Company is a party, more than fifty percent (50%) of the
outstanding voting securities of which are owned in the aggregate by persons who were shareholders of the Company prior to the merger, consolidation or reorganization. 

  

	 	(f)	“Termination Without Cause” means termination of employment of an employee by the Company for a reason other than: (i) conviction of such employee of a crime involving
moral turpitude or a crime for which a term of imprisonment in a federal or state penitentiary is an available sentence, (ii) commission by such employee of any willful malfeasance or gross negligence in the discharge of such employee’s duties
owed to the Company or any of its Subsidiaries that has a material adverse effect on the Company or any of its Subsidiaries, their business or reputations, or (iii) failure by such employee, as determined by the Board of Directors, to correct within
five days after written notice, any specific failure in performance of the duties of the employee owed to the Company or any of its Subsidiaries. Such term shall not include any voluntary termination of employment (including retirement) of an
employee. 

  
 Adopted by the Compensation
Committee on May 18, 2005.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]